Al-one more ACUS thought in retrospect relating to what I have said multiple times on Yahoo over 15 months.

 

Take the current position of ACUS, my 50/50 scenario for success, and replace it with a dilution with 25 million shares at $2.50 or using Azimuth when they had the chance way back prior to Ramp 2 results.  Now many within those boards would have screamed to high heaven, but we would not be where we are today!  They would have 75-80 million shares outstanding (not the end of the world in todays baby bio public companies) and the resiliency to continue on in this environment and get to smotther waters!

 

Then ACUS would be facing maybe more work, with approximately 50 million to do so, No CEPH, Nycomed on the sidelines, the low PPS would not matter so much, and the process would have continued independently.  Could argue the PPS would have been higher in 2H 2008 and the news coming out would have changed the dynamics of the PPS moves!

 

In the end the blame falls on Sherrie as CEO.  This was the ultimate mistake for educational purposes in bio investing!  She did not follow the "holy grail of baby bios"!  Said several times!

 

"Keep yourself funded 12-15 months in advance"!  The rest of the BS here are excuses, politics, changing FDA paradigms, and multiple bad breaks (credit environment in 2H 2008)!

 

She rolled the dice with our cash, and this technology and her endless innuendo on partnerships-GAME OVER!  STICK A FORK IN IT.  She is a loser.

 

Best thing to happen here will be CEPH to buy it and a little run up in current PPS to get out-worst case scenario=0.00!  With what I got left-I am prepared for either eventuality!  Close the dooor-turn the page.

 

No Vegas for us!

 

Kutz